Overview
Beijing-based medical robotics company developing intelligent innovative medical devices, including robotic systems for stereotactic neurosurgery. Founded in 2015, Sinovation Medical has had two products approved by China's National Medical Products Administration (NMPA) and partnered with over 100 top hospitals. The company received investment from Medtronic and develops robotic surgical systems used in neurosurgery applications.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Products
NMPA approvals
Investor
Deployments
Data & sources
Web sources
1
1 source backing this record.View all →
Sinovation Medical on the deployment map
View the global mapSinovation Medical has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Sinovation Medical on the DEPLOY record yet. Track Sinovation Medical to know the moment the first one is verified.
Current leadership (1)
- Wang Jian Founder
Founders (1)
- Wang Jiancofounderno longer at company
later founded BGI Group, BGI Genomics
Safety record
No incidents on record for Sinovation Medical.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Sinovation Medical in third-party press
Peers
41 peers across 1 segment. Every Sinovation Medical competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Andromeda Surgicaldirect competitor(inferred)moderate
- Asensus Surgicaldirect competitor(inferred)moderate
- Boston Scientificdirect competitor(inferred)moderate
- Brain Navidirect competitor(inferred)moderate
- Brainlabdirect competitor(inferred)moderate
- Butterfly Networkdirect competitor(inferred)moderate
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
Sources (1)
Common questions
What is Sinovation Medical?
What does Sinovation Medical make?
Who is the CEO of Sinovation Medical?
Where is Sinovation Medical headquartered?
Is Sinovation Medical a top robotics company?
Is Sinovation Medical safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Sinovation Medical.In the press
Recent coverage mentioning Sinovation Medical from third-party publications. Automatically surfaced; not part of the verified registry record.
A synergistic growth in medical robotics
Nature covers a partnership with Sinovation Medical developing a robotic system for stereotactic neurosurgery, used in 100+ top hospitals.
Medtronic Invests in Beijing Surgical Robots Maker Sinovation
Medtronic invested in Sinovation Medical, a Beijing-based surgical robot maker founded in 2015 with two NMPA-approved products.
Machine-readable surfaces
- Markdown mirror: /companies/sinovation-medical.md
- RSS feed: /companies/sinovation-medical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/f508a997-911a-4afe-abd4-ca71aa0cc4a9
- Revision history: /companies/sinovation-medical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Not enough verified signal yet to place Sinovation Medical against peers. Reality and attention percentiles publish once the underlying record clears its data floor.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 3, 2026